← Leaderboards
James Lincoln Leighton
Columbia Univ New York Morningside
$5,226,295
Attributed
$5,226,295
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $471.6K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,226,295 · 2
By mechanism
R01$5,226,295 · 2
Top collaborators
No co-investigators on record.
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Paul Steven Tanis$131,994
- Christopher D Cox$53,152
- Henry Hess$533,873
Others in their field
Top investigators on “Macrolide Antibiotics”
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Jeremy David Keenan · University Of California, San Francisco$7,227,850
- Amos B Smith · University Of Pennsylvania$7,088,929
- Bonnie W Ramsey · University Of Washington$6,606,602
- David H Sherman · Colorado State University$6,541,803
- William Maurice Shafer · Veterans Health Administration$6,476,394
Research focus
Macrolide AntibioticsAnalogMarinesSuccessDesignComplexBiologicalMarine Natural ProductSpongistatin 1SourceMacrolidesEvaluationReactionMicrotubulesAlkynesAntibioticsDrug Design /Synthesis /ProductionBiological FactorsFamilyBenchmarkingFermentationAntiviral AgentsHydrocarbonsCancer Cell Growth
Grant awards (22)
Asymmetric Synthesis of Marcolide Antibiotics$347,363
R01 · FY2017 · GM · contact PI
Asymmetric Synthesis of Marcolide Antibiotics$344,849
R01 · FY2016 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$80,000
R01 · FY2016 · GM · contact PI
Asymmetric Synthesis of Marcolide Antibiotics$342,408
R01 · FY2015 · GM · contact PI
Asymmetric Synthesis of Marcolide Antibiotics$226,789
R01 · FY2014 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$117,766
R01 · FY2014 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$373,579
R01 · FY2012 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$334,737
R01 · FY2011 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$42,566
R01 · FY2011 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$336,110
R01 · FY2010 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$336,693
R01 · FY2009 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$134,950
R01 · FY2009 · GM · contact PI
Asymmetric Synthesis of Macrolide Antibiotics$306,498
R01 · FY2005 · GM
Asymmetric Synthesis of Macrolide Antibiotics$321,289
R01 · FY2004 · GM
Asymmetric Synthesis of Macrolide Antibiotics$320,132
R01 · FY2003 · GM
Asymmetric Synthesis of Macrolide Antibiotics$13,014
R01 · FY2003 · GM
Asymmetric Synthesis of Macrolide Antibiotics$334,925
R01 · FY2002 · GM
TOTAL SYNTHESIS OF THE FARNESY TRANSFERASE INHIBITOR$180,704
R01 · FY2002 · GM
ASYMMETRIC SYNTHESIS OF MACROLIDE ANTIBIOTICS$194,227
R01 · FY2001 · GM
TOTAL SYNTHESIS OF THE FARNESY TRANSFERASE INHIBITOR$175,516
R01 · FY2001 · GM
ASYMMETRIC SYNTHESIS OF MACROLIDE ANTIBIOTICS$191,702
R01 · FY2000 · GM
TOTAL SYNTHESIS OF THE FARNESY TRANSFERASE INHIBITOR$170,478
R01 · FY2000 · GM